In 1172 adults with HIV admitted to 11 hospitals in Tanzania and Mozambique, expanded Xpert Ultra (sputum, stool, urine) plus urine LF-LAM testing did not raise confirmed TB starting treatment within 72 h v symptom-based testing (16.0% v 15.3%, p=0.73) or cut 8-week mortality.
RCTn = 1,172
Cossa et al. Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial